Transforming growth factor- (TGF-) binds to and signals via two serine-threonine kinase receptors, type I (TRI) and type II (TRII). The oligomerization of TGF- receptors modulates ligand binding and receptor trafficking and may contribute to signal diversification. However, numerous features of the molecular domains that determine the homo-and hetero-oligomerization of full-length receptors at the cell surface and the mode of these interactions remain unclear. Here, we address these questions through computerized immunofluorescence co-patching and patch/fluorescence recovery after photobleaching measurements of different combinations of epitopetagged receptors and their mutants in live cells. We show that TRI and TRII are present on the plasma membrane both as monomers and homo-and hetero-oligomers. The homodimerization of TRII depends on a cytoplasmic juxtamembrane region (amino acid residues 200 -220). In contrast, the cytoplasmic domain of TRI is dispensable for its homodimerization. TRI⅐TRII hetero-oligomerization depends on the cytoplasmic domain of TRI and on a C-terminal region of TRII (residues 419 -565). TGF-1 elevates TRII homodimerization to some degree and strongly enhances TRI⅐TRII heteromeric complex formation. Both ligand-induced effects depend on the region encompassed between residues 200 -242 of TRII. Furthermore, the kinase activity of TRI is also necessary for the latter effect. All forms of the homo-and hetero-oligomers, whether constitutively present on the membrane or formed upon TGF-1 stimulation, were stable in the time-scale of our patch/FRAP measurements. We suggest that the different forms of receptor oligomerization may serve as a basis for the heterogeneity of TGF- signaling responses.
Transforming growth factor- (TGF-)3 comprises a large superfamily of cysteine knot growth factors which regulate diverse biological processes including cell proliferation, differentiation, migration, and death (1-4). They were implicated in embryonic development, immune responses, hematopoiesis, and cancer (1, 2, 4 -6). TGF- signals via two receptor Ser/Thr kinases, type I and type II (TRI and TRII) (3, 4, 7-9). TRII can bind ligands but requires TRI for signaling, whereas TRI alone is incapable of ligand binding (8, 10 -13). TRII is a constitutively active kinase regulated by autophosphorylation (14,15). In the presence of ligand, TRII phosphorylates specific Ser residues in TRI, mediating its activation (13, 16). In turn, TRI phosphorylates Smad2/3 proteins, mediating their translocation together with Smad4 to the nucleus, where they regulate transcription of target genes (2-4, 17).TRI and TRII can physically associate (13, 18 -21). Earlier we demonstrated in live cells that both TRI (22) and TRII (23) can form homodimers even in the absence of ligand, and biological evidence supports the homo-oligomerization of both receptors (12,15,24,25). On the other hand, the tendency of TRI and TRII to form heterotetramers is strongly elevated by .Recent studies have show...